Global Influenza (Flu) Antiviral Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4801121
- 111 Pages
- January 2022
- Pharmaceuticals
The United States Influenza (Flu) Antiviral Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Influenza (Flu) Antiviral Drugs market, reaching US$ million by the year 2028. As for the Europe Influenza (Flu) Antiviral Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Influenza (Flu) Antiviral Drugs players cover Pfizer, Roche, Sanofi, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Influenza (Flu) Antiviral Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Penetration and Dehulling Inhibitors
DNA Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protein Inhibitors
Neuraminidase Inhibitors
Broad-spectrum Antiviral Drugs
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Household
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Influenza (Flu) Antiviral Drugs Market Size 2017-2028
2.1.2 Influenza (Flu) Antiviral Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Influenza (Flu) Antiviral Drugs Segment by Type
2.2.1 Penetration and Dehulling Inhibitors
2.2.2 DNA Polymerase Inhibitors
2.2.3 Reverse Transcriptase Inhibitors
2.2.4 Protein Inhibitors
2.2.5 Neuraminidase Inhibitors
2.2.6 Broad-spectrum Antiviral Drugs
2.3 Influenza (Flu) Antiviral Drugs Market Size by Type
2.3.1 Influenza (Flu) Antiviral Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2022)
2.4 Influenza (Flu) Antiviral Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Household
2.4.4 Others
2.5 Influenza (Flu) Antiviral Drugs Market Size by Application
2.5.1 Influenza (Flu) Antiviral Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2022)
3 Influenza (Flu) Antiviral Drugs Market Size by Player
3.1 Influenza (Flu) Antiviral Drugs Market Size Market Share by Players
3.1.1 Global Influenza (Flu) Antiviral Drugs Revenue by Players (2020-2022)
3.1.2 Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Influenza (Flu) Antiviral Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Influenza (Flu) Antiviral Drugs by Regions
4.1 Influenza (Flu) Antiviral Drugs Market Size by Regions (2017-2022)
4.2 Americas Influenza (Flu) Antiviral Drugs Market Size Growth (2017-2022)
4.3 APAC Influenza (Flu) Antiviral Drugs Market Size Growth (2017-2022)
4.4 Europe Influenza (Flu) Antiviral Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022)
5.2 Americas Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022)
5.3 Americas Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Influenza (Flu) Antiviral Drugs Market Size by Region (2017-2022)
6.2 APAC Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022)
6.3 APAC Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Influenza (Flu) Antiviral Drugs by Country (2017-2022)
7.2 Europe Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022)
7.3 Europe Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Influenza (Flu) Antiviral Drugs by Region (2017-2022)
8.2 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Influenza (Flu) Antiviral Drugs Market Forecast
10.1 Global Influenza (Flu) Antiviral Drugs Forecast by Regions (2023-2028)
10.1.1 Global Influenza (Flu) Antiviral Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Influenza (Flu) Antiviral Drugs Forecast
10.1.3 APAC Influenza (Flu) Antiviral Drugs Forecast
10.1.4 Europe Influenza (Flu) Antiviral Drugs Forecast
10.1.5 Middle East & Africa Influenza (Flu) Antiviral Drugs Forecast
10.2 Americas Influenza (Flu) Antiviral Drugs Forecast by Country (2023-2028)
10.2.1 United States Influenza (Flu) Antiviral Drugs Market Forecast
10.2.2 Canada Influenza (Flu) Antiviral Drugs Market Forecast
10.2.3 Mexico Influenza (Flu) Antiviral Drugs Market Forecast
10.2.4 Brazil Influenza (Flu) Antiviral Drugs Market Forecast
10.3 APAC Influenza (Flu) Antiviral Drugs Forecast by Region (2023-2028)
10.3.1 China Influenza (Flu) Antiviral Drugs Market Forecast
10.3.2 Japan Influenza (Flu) Antiviral Drugs Market Forecast
10.3.3 Korea Influenza (Flu) Antiviral Drugs Market Forecast
10.3.4 Southeast Asia Influenza (Flu) Antiviral Drugs Market Forecast
10.3.5 India Influenza (Flu) Antiviral Drugs Market Forecast
10.3.6 Australia Influenza (Flu) Antiviral Drugs Market Forecast
10.4 Europe Influenza (Flu) Antiviral Drugs Forecast by Country (2023-2028)
10.4.1 Germany Influenza (Flu) Antiviral Drugs Market Forecast
10.4.2 France Influenza (Flu) Antiviral Drugs Market Forecast
10.4.3 UK Influenza (Flu) Antiviral Drugs Market Forecast
10.4.4 Italy Influenza (Flu) Antiviral Drugs Market Forecast
10.4.5 Russia Influenza (Flu) Antiviral Drugs Market Forecast
10.5 Middle East & Africa Influenza (Flu) Antiviral Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Influenza (Flu) Antiviral Drugs Market Forecast
10.5.2 South Africa Influenza (Flu) Antiviral Drugs Market Forecast
10.5.3 Israel Influenza (Flu) Antiviral Drugs Market Forecast
10.5.4 Turkey Influenza (Flu) Antiviral Drugs Market Forecast
10.5.5 GCC Countries Influenza (Flu) Antiviral Drugs Market Forecast
10.6 Global Influenza (Flu) Antiviral Drugs Forecast by Type (2023-2028)
10.7 Global Influenza (Flu) Antiviral Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Influenza (Flu) Antiviral Drugs Product Offered
11.1.3 Pfizer Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Influenza (Flu) Antiviral Drugs Product Offered
11.2.3 Roche Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Influenza (Flu) Antiviral Drugs Product Offered
11.3.3 Sanofi Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Influenza (Flu) Antiviral Drugs Product Offered
11.4.3 Johnson & Johnson Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Information
11.5.2 Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Product Offered
11.5.3 Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Merck & Co. (MSD) Main Business Overview
11.5.5 Merck & Co. (MSD) Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Influenza (Flu) Antiviral Drugs Product Offered
11.6.3 Novartis Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 AbbVie
11.7.1 AbbVie Company Information
11.7.2 AbbVie Influenza (Flu) Antiviral Drugs Product Offered
11.7.3 AbbVie Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 AbbVie Main Business Overview
11.7.5 AbbVie Latest Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Information
11.8.2 Gilead Sciences Influenza (Flu) Antiviral Drugs Product Offered
11.8.3 Gilead Sciences Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Gilead Sciences Main Business Overview
11.8.5 Gilead Sciences Latest Developments
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Information
11.9.2 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Product Offered
11.9.3 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 GlaxoSmithKline (GSK) Main Business Overview
11.9.5 GlaxoSmithKline (GSK) Latest Developments
11.10 Amgen
11.10.1 Amgen Company Information
11.10.2 Amgen Influenza (Flu) Antiviral Drugs Product Offered
11.10.3 Amgen Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Amgen Main Business Overview
11.10.5 Amgen Latest Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Information
11.11.2 AstraZeneca Influenza (Flu) Antiviral Drugs Product Offered
11.11.3 AstraZeneca Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 AstraZeneca Main Business Overview
11.11.5 AstraZeneca Latest Developments
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Information
11.12.2 Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Product Offered
11.12.3 Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Bristol-Myers Squibb Main Business Overview
11.12.5 Bristol-Myers Squibb Latest Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Information
11.13.2 Eli Lilly Influenza (Flu) Antiviral Drugs Product Offered
11.13.3 Eli Lilly Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Eli Lilly Main Business Overview
11.13.5 Eli Lilly Latest Developments
11.14 Teva
11.14.1 Teva Company Information
11.14.2 Teva Influenza (Flu) Antiviral Drugs Product Offered
11.14.3 Teva Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Teva Main Business Overview
11.14.5 Teva Latest Developments
11.15 Bayer
11.15.1 Bayer Company Information
11.15.2 Bayer Influenza (Flu) Antiviral Drugs Product Offered
11.15.3 Bayer Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Bayer Main Business Overview
11.15.5 Bayer Latest Developments
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Information
11.16.2 Novo Nordisk Influenza (Flu) Antiviral Drugs Product Offered
11.16.3 Novo Nordisk Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Novo Nordisk Main Business Overview
11.16.5 Novo Nordisk Latest Developments
11.17 Allergan
11.17.1 Allergan Company Information
11.17.2 Allergan Influenza (Flu) Antiviral Drugs Product Offered
11.17.3 Allergan Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Allergan Main Business Overview
11.17.5 Allergan Latest Developments
11.18 Takeda
11.18.1 Takeda Company Information
11.18.2 Takeda Influenza (Flu) Antiviral Drugs Product Offered
11.18.3 Takeda Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Takeda Main Business Overview
11.18.5 Takeda Latest Developments
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Information
11.19.2 Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Product Offered
11.19.3 Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Boehringer Ingelheim Main Business Overview
11.19.5 Boehringer Ingelheim Latest Developments
12 Research Findings and Conclusion
Table 1. Influenza (Flu) Antiviral Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Penetration and Dehulling Inhibitors
Table 3. Major Players of DNA Polymerase Inhibitors
Table 4. Major Players of Reverse Transcriptase Inhibitors
Table 5. Major Players of Protein Inhibitors
Table 6. Major Players of Neuraminidase Inhibitors
Table 7. Major Players of Broad-spectrum Antiviral Drugs
Table 8. Influenza (Flu) Antiviral Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 10. Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2022)
Table 11. Influenza (Flu) Antiviral Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 12. Global Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 13. Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2022)
Table 14. Global Influenza (Flu) Antiviral Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 15. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Player (2020-2022)
Table 16. Influenza (Flu) Antiviral Drugs Key Players Head office and Products Offered
Table 17. Influenza (Flu) Antiviral Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Influenza (Flu) Antiviral Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 21. Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Regions (2017-2022)
Table 22. Americas Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 23. Americas Influenza (Flu) Antiviral Drugs Market Size Market Share by Country (2017-2022)
Table 24. Americas Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 25. Americas Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2022)
Table 26. Americas Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 27. Americas Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2022)
Table 28. APAC Influenza (Flu) Antiviral Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 29. APAC Influenza (Flu) Antiviral Drugs Market Size Market Share by Region (2017-2022)
Table 30. APAC Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 31. APAC Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2022)
Table 32. APAC Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 33. APAC Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2022)
Table 34. Europe Influenza (Flu) Antiviral Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 35. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Country (2017-2022)
Table 36. Europe Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 37. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2022)
Table 38. Europe Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 39. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2022)
Table 40. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Region (2017-2022)
Table 42. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2017-2022)
Table 44. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2017-2022)
Table 46. Key Market Drivers & Growth Opportunities of Influenza (Flu) Antiviral Drugs
Table 47. Key Market Challenges & Risks of Influenza (Flu) Antiviral Drugs
Table 48. Key Industry Trends of Influenza (Flu) Antiviral Drugs
Table 49. Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 50. Global Influenza (Flu) Antiviral Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 51. Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 52. Global Influenza (Flu) Antiviral Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 53. Global Influenza (Flu) Antiviral Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 54. Global Influenza (Flu) Antiviral Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 55. Pfizer Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 56. Pfizer Influenza (Flu) Antiviral Drugs Product Offered
Table 57. Pfizer Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 58. Pfizer Main Business
Table 59. Pfizer Latest Developments
Table 60. Roche Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 61. Roche Influenza (Flu) Antiviral Drugs Product Offered
Table 62. Roche Main Business
Table 63. Roche Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 64. Roche Latest Developments
Table 65. Sanofi Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 66. Sanofi Influenza (Flu) Antiviral Drugs Product Offered
Table 67. Sanofi Main Business
Table 68. Sanofi Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 69. Sanofi Latest Developments
Table 70. Johnson & Johnson Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 71. Johnson & Johnson Influenza (Flu) Antiviral Drugs Product Offered
Table 72. Johnson & Johnson Main Business
Table 73. Johnson & Johnson Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 74. Johnson & Johnson Latest Developments
Table 75. Merck & Co. (MSD) Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 76. Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Product Offered
Table 77. Merck & Co. (MSD) Main Business
Table 78. Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 79. Merck & Co. (MSD) Latest Developments
Table 80. Novartis Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 81. Novartis Influenza (Flu) Antiviral Drugs Product Offered
Table 82. Novartis Main Business
Table 83. Novartis Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 84. Novartis Latest Developments
Table 85. AbbVie Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 86. AbbVie Influenza (Flu) Antiviral Drugs Product Offered
Table 87. AbbVie Main Business
Table 88. AbbVie Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 89. AbbVie Latest Developments
Table 90. Gilead Sciences Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 91. Gilead Sciences Influenza (Flu) Antiviral Drugs Product Offered
Table 92. Gilead Sciences Main Business
Table 93. Gilead Sciences Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 94. Gilead Sciences Latest Developments
Table 95. GlaxoSmithKline (GSK) Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 96. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Product Offered
Table 97. GlaxoSmithKline (GSK) Main Business
Table 98. GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 99. GlaxoSmithKline (GSK) Latest Developments
Table 100. Amgen Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 101. Amgen Influenza (Flu) Antiviral Drugs Product Offered
Table 102. Amgen Main Business
Table 103. Amgen Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Amgen Latest Developments
Table 105. AstraZeneca Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 106. AstraZeneca Influenza (Flu) Antiviral Drugs Product Offered
Table 107. AstraZeneca Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 108. AstraZeneca Main Business
Table 109. AstraZeneca Latest Developments
Table 110. Bristol-Myers Squibb Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 111. Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Product Offered
Table 112. Bristol-Myers Squibb Main Business
Table 113. Bristol-Myers Squibb Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 114. Bristol-Myers Squibb Latest Developments
Table 115. Eli Lilly Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 116. Eli Lilly Influenza (Flu) Antiviral Drugs Product Offered
Table 117. Eli Lilly Main Business
Table 118. Eli Lilly Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 119. Eli Lilly Latest Developments
Table 120. Teva Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 121. Teva Influenza (Flu) Antiviral Drugs Product Offered
Table 122. Teva Main Business
Table 123. Teva Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 124. Teva Latest Developments
Table 125. Bayer Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 126. Bayer Influenza (Flu) Antiviral Drugs Product Offered
Table 127. Bayer Main Business
Table 128. Bayer Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 129. Bayer Latest Developments
Table 130. Novo Nordisk Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 131. Novo Nordisk Influenza (Flu) Antiviral Drugs Product Offered
Table 132. Novo Nordisk Main Business
Table 133. Novo Nordisk Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 134. Novo Nordisk Latest Developments
Table 135. Allergan Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 136. Allergan Influenza (Flu) Antiviral Drugs Product Offered
Table 137. Allergan Main Business
Table 138. Allergan Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 139. Allergan Latest Developments
Table 140. Takeda Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 141. Takeda Influenza (Flu) Antiviral Drugs Product Offered
Table 142. Takeda Main Business
Table 143. Takeda Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 144. Takeda Latest Developments
Table 145. Boehringer Ingelheim Details, Company Type, Influenza (Flu) Antiviral Drugs Area Served and Its Competitors
Table 146. Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Product Offered
Table 147. Boehringer Ingelheim Main Business
Table 148. Boehringer Ingelheim Influenza (Flu) Antiviral Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 149. Boehringer Ingelheim Latest Developments
List of Figures
Figure 1. Influenza (Flu) Antiviral Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Type in 2021
Figure 7. Influenza (Flu) Antiviral Drugs in Hospital
Figure 8. Global Influenza (Flu) Antiviral Drugs Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Influenza (Flu) Antiviral Drugs in Clinic
Figure 10. Global Influenza (Flu) Antiviral Drugs Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Influenza (Flu) Antiviral Drugs in Household
Figure 12. Global Influenza (Flu) Antiviral Drugs Market: Household (2017-2022) & ($ Millions)
Figure 13. Influenza (Flu) Antiviral Drugs in Others
Figure 14. Global Influenza (Flu) Antiviral Drugs Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Application in 2021
Figure 16. Global Influenza (Flu) Antiviral Drugs Revenue Market Share by Player in 2021
Figure 17. Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Influenza (Flu) Antiviral Drugs Market Size 2017-2022 ($ Millions)
Figure 19. APAC Influenza (Flu) Antiviral Drugs Market Size 2017-2022 ($ Millions)
Figure 20. Europe Influenza (Flu) Antiviral Drugs Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size 2017-2022 ($ Millions)
Figure 22. Americas Influenza (Flu) Antiviral Drugs Value Market Share by Country in 2021
Figure 23. Americas Influenza (Flu) Antiviral Drugs Consumption Market Share by Type in 2021
Figure 24. Americas Influenza (Flu) Antiviral Drugs Market Size Market Share by Application in 2021
Figure 25. United States Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Influenza (Flu) Antiviral Drugs Market Size Market Share by Region in 2021
Figure 30. APAC Influenza (Flu) Antiviral Drugs Market Size Market Share by Application in 2021
Figure 31. China Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Country in 2021
Figure 38. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Type in 2021
Figure 39. Europe Influenza (Flu) Antiviral Drugs Market Size Market Share by Application in 2021
Figure 40. Germany Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Market Share by Application in 2021
Figure 48. Egypt Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Influenza (Flu) Antiviral Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 54. APAC Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Europe Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 57. United States Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Canada Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 61. China Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Japan Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Korea Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 65. India Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Australia Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Germany Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 68. France Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 69. UK Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Italy Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Russia Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Spain Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 75. Israel Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Influenza (Flu) Antiviral Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
